Cara Therapeutics, Inc. (LON:0HTC)

Cara Therapeutics Revenue

Cara Therapeutics had revenue of $2.56M USD in the quarter ending September 30, 2024, a decrease of -47.47%. This brings the company's revenue in the last twelve months to $8.69M, down -59.08% year-over-year. In the year 2023, Cara Therapeutics had annual revenue of $20.97M, down -49.92%.

• Revenue (ttm): $8.69M
• Revenue Growth: -59.08%
• P/S Ratio: n/a
• Revenue / Employee: $157.93K
• Employees: 55
• Market Cap: 17.97M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	20.97M	-20.90M	-49.92%
Dec 31, 2022	41.87M	18.84M	81.81%
Dec 31, 2021	23.03M	-112.05M	-82.95%
Dec 31, 2020	135.08M	115.20M	579.28%
Dec 31, 2019	19.89M	6.42M	47.64%